{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T15:55:40Z","timestamp":1757778940965},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.taap.2016.12.017","type":"journal-article","created":{"date-parts":[[2016,12,28]],"date-time":"2016-12-28T08:46:39Z","timestamp":1482914799000},"page":"123-138","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Carbonic anhydrase inhibition boosts the antitumor effects of Imatinib mesylate via potentiating the antiangiogenic and antimetastatic machineries"],"prefix":"10.1016","volume":"316","author":[{"given":"Amal A.","family":"Abd-El Fattah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hebatallah A.","family":"Darwish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nevine","family":"Fathy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samia A.","family":"Shouman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2016.12.017_bb0005","first-page":"520","article-title":"NIH public access","volume":"141","author":"Angelica","year":"2008","journal-title":"October"},{"key":"10.1016\/j.taap.2016.12.017_bb0010","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1164\/rccm.200404-531OC","article-title":"Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice","volume":"171","author":"Aono","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.taap.2016.12.017_bb0015","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1590\/S0100-879X2006005000109","article-title":"A mechanistic view of mitochondrial death decision pores","volume":"40","author":"Beliz\u00e1rio","year":"2007","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.taap.2016.12.017_bb0020","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3802\/jgo.2011.22.4.225","article-title":"Combination of imatinib mesylate with lithium chloride and medroxyprogesterone acetate is highly active in Ishikawa endometrial carcinoma in vitro","volume":"22","author":"Bilir","year":"2011","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.taap.2016.12.017_bb0025","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.taap.2016.12.017_bb0030","first-page":"710","article-title":"Selective inhibition of carbonic anhydrase IX decreases cell proliferation and induces ceramide-mediated apoptosis in human cancer cells","volume":"334","author":"Cianchi","year":"2010","journal-title":"Pharmacology"},{"key":"10.1016\/j.taap.2016.12.017_bb0035","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.radonc.2011.05.045","article-title":"Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation","volume":"99","author":"Dubois","year":"2011","journal-title":"Radiother. Oncol."},{"issue":"3","key":"10.1016\/j.taap.2016.12.017_bb0040","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/01.ATV.20.3.659","article-title":"Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells","volume":"20","author":"Dulak","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.taap.2016.12.017_bb0045","first-page":"89","article-title":"Imatinib mesylate (STI-571) reduces Bcr-Abl-mediated vascular endothelial growth factor secretion in chronic myelogenous leukemia","volume":"1","author":"Ebos","year":"2002","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.taap.2016.12.017_bb0050","series-title":"NIH Public Access 18","first-page":"1492","author":"Gatzeva-topalova","year":"2011"},{"key":"10.1016\/j.taap.2016.12.017_bb0055","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3109\/14756366.2012.736979","article-title":"Inhibition of carbonic anhydrase activity modifies the toxicity of doxorubicin and melphalan in tumour cells in vitro","volume":"28","author":"Gieling","year":"2013","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.taap.2016.12.017_bb0060","doi-asserted-by":"crossref","first-page":"6494","DOI":"10.1158\/0008-5472.CAN-13-1110","article-title":"Antitumor efficacy of a monoclonal antibody that inhibits the activity of cancer-associated carbonic anhydrase XII","volume":"73","author":"Gondi","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2016.12.017_bb0065","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ejcb.2010.03.004","article-title":"Carbonic anhydrase XII promotes invasion and migration ability of MDA-MB-231 breast cancer cells through the p38 MAPK signaling pathway","volume":"89","author":"Hsieh","year":"2010","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.taap.2016.12.017_bb0070","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1046\/j.1365-2036.2003.01738.x","article-title":"Expression of carbonic anhydrase IX in human pancreatic cancer","volume":"18","author":"Juh\u00e1sz","year":"2003","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.taap.2016.12.017_bb0075","doi-asserted-by":"crossref","first-page":"11055","DOI":"10.3390\/ijms160511055","article-title":"Molecular connections between cancer cell metabolism and the tumor microenvironment","volume":"16","author":"Justus","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2016.12.017_bb0080","first-page":"613","article-title":"NIH public access","volume":"27","author":"Li","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2016.12.017_bb0085","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.taap.2016.12.017_bb0090","first-page":"264","article-title":"Manipulating tumor acidification as a cancer treatment strategy","volume":"15","author":"McCarty","year":"2010","journal-title":"Altern. Med. Rev."},{"key":"10.1016\/j.taap.2016.12.017_bb0095","doi-asserted-by":"crossref","first-page":"84","DOI":"10.18632\/oncotarget.422","article-title":"Recent developments in targeting carbonic anhydrase IX for cancer therapeutics","volume":"3","author":"McDonald","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.taap.2016.12.017_bb0100","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1006\/niox.2000.0319","article-title":"A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite","volume":"5","author":"Miranda","year":"2001","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.taap.2016.12.017_bb0105","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1073\/pnas.040554897","article-title":"Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro","volume":"97","author":"Parkkila","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2016.12.017_bb0110","series-title":"PDGF and PDGF-R \u03b1\/\u03b2Expression in Squamous Cell Carcinoma of the Head and Neck in Vitro","first-page":"1001","article-title":"Synergistic effects of imatinib and carboplatin on VEGF","author":"Schultz","year":"2011"},{"key":"10.1016\/j.taap.2016.12.017_bb0115","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","article-title":"New colorimetric cytotoxicity assay for anticancer-drug screening","volume":"82","author":"Skehan","year":"1990","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.taap.2016.12.017_bb0120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/biomedicines3010071","article-title":"HGF\/c-MET axis in tumor microenvironment and metastasis formation","volume":"3","author":"Spina","year":"2015","journal-title":"Biomedicines"},{"key":"10.1016\/j.taap.2016.12.017_bb0125","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1002\/ijc.23029","article-title":"Imatinib inhibits colorectal cancer cell growth and suppresses stromal-induced growth stimulation, MT1-MMP expression and pro-MMP2 activation","volume":"121","author":"Stahtea","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.taap.2016.12.017_bb0130","first-page":"1549","article-title":"A carbonic anhydrase inhibitor as a potential modulator of cancer therapies","volume":"13","author":"Teicher","year":"1993","journal-title":"Anticancer Res."},{"key":"10.1016\/j.taap.2016.12.017_bb0135","first-page":"812","article-title":"Acetazolamide inhibits aquaporin-1 protein expression and angiogenesis","volume":"25","author":"Xiang","year":"2004","journal-title":"Acta Pharmacol. Sin."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X16303969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X16303969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T01:02:08Z","timestamp":1568682128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X16303969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":27,"alternative-id":["S0041008X16303969"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2016.12.017","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carbonic anhydrase inhibition boosts the antitumor effects of Imatinib mesylate via potentiating the antiangiogenic and antimetastatic machineries","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2016.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}